Innovate UK Biomedical Catalyst

HIGH Tx Startup

Strategy Notes

The Biomedical Catalyst grant supports early‑stage biotech SMEs developing innovative therapeutic solutions, directly aligning with the venture’s AI‑driven drug resistance prediction platform. Its non‑dilutive funding model matches the applicant’s request for €30K–€2.5M, and the UK focus complements the founder’s plan to target EU and UK markets.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: rolling
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-24 OPEN → INELIGIBLE · The programme is a specific Microbials Accelerator that has already concluded (companies secured funding, programme delivered). The Biomedical Catalyst grant referenced is only available to UK-based SMEs, and the applicant is not yet incorporated and is targeting EU/France, not UK. Additionally, the page describes a past accelerator cohort, not an open rolling grant application.